Lonza outlines strategy for investors

Swiss healthcare manufacturing organization Lonza (SWX: LONN) saw its shares rise 7% to 559.40 francs in early trading, as it announced an overview of its strategy and new organizational structure at its Investor Update 2024.

This included a vision for a simplified organizational structure and an overview of the “One Lonza” strategy propelled by the “Lonza Engine”. This is based around four key initiatives: (1) Focus on the contract development and manufacturing organization (CDMO) business, (2) Reshape the operating model, (3) Elevate execution in manufacturing and engineering, and (4) Expand through an impartial approach to buy and build.

Lonza said the strategy is designed to protect and enhance key Lonza business strengths, including long-term customer relationships, an excellent industry reputation, cutting-edge science and technology for emerging and complex modalities, and a critical mass of assets in key strategic regions.